Table 2.
Baseline characteristics of participants by group.
| Parameters | Total (N = 122) | Group | P value | |
|---|---|---|---|---|
| Control (N = 59) | Experimental (N = 63) | |||
| Age (male) | <0.001 | |||
| 19-29 | 2 (1.6) | 1 (45) | 1 (45) | |
| 30-39 | 8 (6.6) | 6 (27.3) | 2 (9.1) | |
| 40-49 | 7 (5.7) | 4 (18.2) | 3 (13.6) | |
| 50+ | 27 (22.1) | 11 (50) | 16 (72.7) | |
| Age (female) | 0.100 | |||
| 19-29 | 2 (1.6) | 0 (0.0) | 2 (4.9) | |
| 30-39 | 7 (5.7) | 4 (10.8) | 3 (7.3) | |
| 40-49 | 23 (18.9) | 15 (40.5) | 8 (19.5) | |
| 50+ | 46 (37.7) | 18 (48.6) | 28 (68.3) | |
| Gender | 0.467 | |||
| Female | 78 (63.9) | 37 (47.4) | 41 (52.5) | |
| Male | 44 (36.1) | 22 (50.0) | 22 (50.0) | |
| Comorbidities | 0.122 | |||
| Chol | 6 (4.9) | 3 (50.0) | 3 (50.0) | |
| Chol, DM | 1 (0.8) | 1 (100.0) | 0 (0.0) | |
| Chol, Hpt | 32 (26.2) | 11 (33.3) | 21 (66.6) | |
| Chol, Hpt, DM | 8 (6.6) | 2 (25.0) | 6 (75.0) | |
| Hpt | 63 (51.6) | 37 (58.7) | 26 (41.2) | |
| Hpt, DM | 9 (7.4) | 5 (55.5) | 4 (44.4) | |
| Hpt, stroke | 1 (0.8) | 0 (0.0) | 1 (100.0) | |
| Stroke | 1 (0.8) | 0 (0.0) | 1 (100.0) | |
| Social history | ||||
| Tobacco use | 0.628 | |||
| Tobacco users | 116 (9) | 56 (48.3) | 60 (51.7) | |
| Nontobacco users | 6 (5) | 3 (50.0) | 3 (50.0) | |
| Alcohol intake | 0.484 | |||
| Drink alcohol | 121 (99.2) | 58 (47.9) | 63 (52.0) | |
| Nonalcoholic | 1 (0.8) | 1 (100.0) | 0 (0.0) | |
| Medication | 46 (37.7) | N = 18 | N = 28 | 0.890 |
| Atorvastatin (10 mg) | 8 (28.6) | 7 (38.9) | 15 (32.6) | |
| Atorvastatin (20 mg) | 7 (25.0) | 4 (22.2) | 11 (23.9) | |
| Crestor (10 mg) | 6 (21.4) | 6 (33.3) | 12 (26.1) | |
| Crestor (20 mg) | 5 (17.9) | 1 (5.6) | 6 (13.0) | |
| Simvastatin (40 mg) | 2 (7.1) | 0 (0.0) | 2 (4.3) | |
Data shows frequencies (percentages) of categorical variables; some cells were less than 5 so Fisher's exact P value was reported. Chol: cholesterol; DM: diabetes mellitus; Hpt: hypertension. Others: pastor, hairdresser, and artisan. The bold value is significant at P < 0.05.